89 related articles for article (PubMed ID: 1840024)
1. FDA authorizes wider use of new oral medication for AIDS.
Oncology (Williston Park); 1991 Dec; 5(12):59. PubMed ID: 1840024
[No Abstract] [Full Text] [Related]
2. AIDS-related treatment receives IND status.
J Am Osteopath Assoc; 1992 Jan; 92(1):46. PubMed ID: 1559856
[No Abstract] [Full Text] [Related]
3. Treatment IND protocol announced for Pneumocystis carinii pneumonia.
Clin Pharm; 1992 Feb; 11(2):99, 103. PubMed ID: 1551304
[No Abstract] [Full Text] [Related]
4. New AIDS drug available.
AORN J; 1992 Feb; 55(2):514. PubMed ID: 1536543
[No Abstract] [Full Text] [Related]
5. A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome.
Falloon J; Kovacs J; Hughes W; O'Neill D; Polis M; Davey RT; Rogers M; LaFon S; Feuerstein I; Lancaster D
N Engl J Med; 1991 Nov; 325(22):1534-8. PubMed ID: 1944437
[TBL] [Abstract][Full Text] [Related]
6. New oral agent for PCP is effective, well tolerated.
Oncology (Williston Park); 1992 Sep; 6(9):88. PubMed ID: 1449979
[No Abstract] [Full Text] [Related]
7. Atovaquone to be marketed as oral therapy for Pneumocystis carinii pneumonia.
Clin Pharm; 1993 Mar; 12(3):175-6. PubMed ID: 8491073
[No Abstract] [Full Text] [Related]
8. Atovaquone: a new oral treatment for pneumocystis.
Nurse Pract; 1993 Sep; 18(9):22. PubMed ID: 8414230
[No Abstract] [Full Text] [Related]
9. Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia.
White A; LaFon S; Rogers M; Andrews E; Brown N
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):280-5. PubMed ID: 7788426
[TBL] [Abstract][Full Text] [Related]
10. Atovaquone as prophylaxis for Pneumocystis carinii.
Vilar FJ; McKendrick MW; Nash C
Int J STD AIDS; 1996 Jul; 7(4):302. PubMed ID: 8876368
[No Abstract] [Full Text] [Related]
11. FDA approves wider use of aerosolized pentamidine to prevent pneumocystis pneumonia.
Oncology (Williston Park); 1989 Mar; 3(3):54. PubMed ID: 2641319
[No Abstract] [Full Text] [Related]
12. FDA approves new PCP drug. Food and Drug Administration.
AIDS Alert; 1995 Aug; 10(8):108. PubMed ID: 11362680
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS.
Kazanjian P; Armstrong W; Hossler PA; Lee CH; Huang L; Beard CB; Carter J; Crane L; Duchin J; Burman W; Richardson J; Meshnick SR
J Infect Dis; 2001 Mar; 183(5):819-22. PubMed ID: 11181161
[TBL] [Abstract][Full Text] [Related]
14. Rapid high-performance liquid chromatographic assay for atovaquone.
Hansson AG; Mitchell S; Jatlow P; Rainey PM
J Chromatogr B Biomed Appl; 1996 Jan; 675(1):180-2. PubMed ID: 8634763
[TBL] [Abstract][Full Text] [Related]
15. Atovaquone: a new antipneumocystis agent.
Artymowicz RJ; James VE
Clin Pharm; 1993 Aug; 12(8):563-70. PubMed ID: 8222520
[TBL] [Abstract][Full Text] [Related]
16. Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.
Safrin S
Semin Respir Infect; 1993 Jun; 8(2):96-103. PubMed ID: 8278684
[TBL] [Abstract][Full Text] [Related]
17. [Pentamidine inhalation for Pneumocystis carinii pneumonia in AIDS].
Pines A; Giladi M; Moshkowitz M; Finkelstein A; Levo Y
Harefuah; 1989 Mar; 116(6):311-2. PubMed ID: 2786489
[TBL] [Abstract][Full Text] [Related]
18. [Glucocorticoids in AIDS-associated Pneumocystis carinii pneumonia].
Dtsch Med Wochenschr; 1991 Feb; 116(6):239. PubMed ID: 1993439
[No Abstract] [Full Text] [Related]
19. Adjunctive corticosteroid therapy for pneumocystis pneumonia in patients with AIDS.
Siwek J
Am Fam Physician; 1991 Aug; 44(2):447-8. PubMed ID: 1858601
[No Abstract] [Full Text] [Related]
20. [Use of corticosteroids in pneumonia caused by Pneumocystis carinii-AIDS with lack of response to conventional therapy].
Martínez Vázquez C; Fandiño A; Bandrés R; Torres J
Rev Clin Esp; 1989 Jun; 185(2):108-9. PubMed ID: 2788904
[No Abstract] [Full Text] [Related]
[Next] [New Search]
